Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Intramural Needle Ablation for Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation

NCT02799693 is registered in ClinicalTrials.gov with John Sapp as lead sponsor.

NCT NCT02799693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02799693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Intramural Needle Ablation for Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation
Lead sponsor
John Sapp
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
May 30, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent ventricular tachycardia